George K. Ng, CEO of Processa Pharmaceuticals PCSA, has filed 11 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $49.2K. The latest trade was on 06/15.

GN

GN

George K. Ng

CEO

Company

Processa Pharmaceuticals PCSA

First filing

23/08/09

Trades

25 trades

Buys / sales

11 / 0

12-month net buying

$49.2K

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Processa PharmaceuticalsPCSA	Open-market buy	06/15	06/16	2,465 sh	$2.22	$5,472.3	+24.7%
Processa PharmaceuticalsPCSA	Open-market buy	05/29	06/01	2,129 sh	$2.57	$5,471.53	+27.2%
Processa PharmaceuticalsPCSA	Open-market buyAmendment	04/15–05/15	05/19	3,686 sh2 trades	$2.97avg.	$10,947.42	+88.7%
Processa PharmaceuticalsPCSA	Open-market buy	04/30	05/01	2,034 sh	$2.69	$5,471.46	+51.1%
Processa PharmaceuticalsPCSA	Open-market buyAmendment	03/31–04/15	04/30	3,979 sh2 trades	$2.74avg.	$10,899.15	No record
Processa PharmaceuticalsPCSA	Open-market buy	04/15	04/17	1,843 sh	$2.97	$5,473.71	+50.5%
Processa PharmaceuticalsPCSA	Open-market buy	03/31	04/01	2,136 sh	$2.54	$5,425.44	+141.2%
Processa PharmaceuticalsPCSA	Open-market buy	25/01/27	25/01/29	87,200 sh	$0.80	$69,760	No record
Processa PharmaceuticalsPCSA	Open-market buy	24/01/30	24/01/31	10,000 sh	$2.70	$27,000	+100.0%